Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced that Dr. Helen Torley, president and chief executive officer, is scheduled to participate and host investor meetings at the...

Optimized subcutaneous (SC) administration of BHV-1400 achieved rapid, deep, selective, and sustained lowering of Gd-IgA1, differentiating Biohaven's leading TRAP degrader for IgAN from the...

Kyndryl (NYSE: KD), a leading provider of mission-critical enterprise technology services, today announced that Chief Financial Officer David Wyshner will speak at the Bank of America Global...

Vision + Velocity: A Premier Gathering for Executive Leaders Driving the Future of Business CHICAGO, May 28, 2025 /PRNewswire/ -- NextUp, a leading membership organization building the next...

PartsSource, the leading technology and enterprise software platform for managing mission-critical healthcare equipment, announced the opening of its state-of-the-art Customer Experience Center at...